Clinical trial
Study of the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor…
NCT00369434 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00369434 |
|---|---|
| Title | Study of the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor Symptoms in Postmenopausal Women |
| Official title | A Double-Blind, Randomized, Placebo-Controlled, Efficacy and Safety Study of DVS SR for Treatment of Vasomotor Symptoms Associated With Menopause |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Menopause, Vasomotor System |
| Intervention type | Drug |
| Interventions | Desvenlafaxine succinate sustained-release (DVS SR) |
| Enrollment | 450 |
| Start date | Jun 1, 2006 |
| Completion | Feb 1, 2007 |
| First posted | Aug 29, 2006 |
| Last update posted | Jun 1, 2007 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: